Home Therapy with Subcutaneous Anti-Immunoglobulin-E Antibody Omalizumab in 25 Patients with Immunoglobulin-E-Mediated (Allergic) Asthma

By Liebhaber Myron   Dyer Zeb  

Journal of Asthma, Vol. 44, Iss. 3, 2007-04 ,pp. : 195-196

Informa Healthcare

Access to resources Recommend Favorite

Treating Moderate-to-Severe Allergic Asthma with a Recombinant Humanized Anti-IgE Monoclonal Antibody (Omalizumab)

By D'Amato Gennaro  

Treatments in Respiratory Medicine, Vol. 5, Iss. 6, 2006-01 ,pp. : 393-398

Adis International

Access to resources Recommend Favorite

Atopy and Role of Mast Cells in IgE-Mediated Allergic Diseases

By  

Current Immunology Reviews, Vol. 9, Iss. 4, 2013-01 ,pp. : 249-260

Bentham Science Publishers

Access to resources Recommend Favorite

Effectiveness of Omalizumab in a Patient with Severe Asthma, Low Serum IgE Level, and Lack of Sensitized Allergens Induced by Oral Steroid Therapy: The Usefulness of Impulse Oscillation for Assessment of Omalizumab Therapy

By Matsuno Osamu   Komori Chika   Hang Yuki   Matsumoto Tomoshige   Minamoto Seijiro  

Journal of Asthma, Vol. 49, Iss. 8, 2012-10 ,pp. : 839-842

Informa Healthcare

Access to resources Recommend Favorite

Clinically Significant Variability of Serum IgE Concentrations in Patients with Severe Asthma

By Mummadi Srinivas R.   Hatipoğğlu Umur Sevket   Gupta Manjula   Bossard Mary Kay   Xu Meng   Lang David  

Journal of Asthma, Vol. 49, Iss. 2, 2012-03 ,pp. : 115-120

Informa Healthcare

Access to resources Recommend Favorite